The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
WASHINGTON, June 27 (Reuters) - U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's (GSK.L), opens new tab decision to ...
Add Yahoo as a preferred source to see more of our stories on Google. A major pharmaceutical company ended price hikes and monopoly protection over a life-saving asthma inhaler following two years of ...
GlaxoSmithKline and Madison, Wisconsin-based Propeller Health announced a partnership today in which Propeller will develop and manufacture a custom sensor for GSK's Ellipta inhaler for COPD patients.
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
President Joe Biden’s career-defining victories over Big Pharma — reforming Medicare to lower prices and capping inhaler costs for millions of Americans with lung disease — are facing an unlikely ...
Ellipta inhaler sits cold and matte on the stainless tray in a Bronx pulmonary clinic, its oval body small enough to disappear in a patient’s palm as respiratory therapist Maria López clicks open the ...
Boehringer Ingelheim GmbH’s and Astrazeneca plc’s implementation of a $35 monthly U.S. price cap on inhalers for asthma and chronic obstructive pulmonary disease is adding to the pressure on Prasco ...
Add Yahoo as a preferred source to see more of our stories on Google. Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results